American Gene Technologies is a pioneering biotech company headquartered in Rockville, Maryland, that’s using gene therapy to cure humanity’s most deadly diseases. American Gene™ is creating the foundation for a fundamentally new approach to medicine. Much like Apple’s iOS platform for the iPhone, we're building a gene therapy platform, so other scientists can build on its approach to develop new cures (much like software developers creating apps for the iPhone). This will significantly cut the time and costs of developing new drugs for a variety of diseases.

Argo Graphene Solutions Corp. is a Canadian advanced materials company developing and commercializing graphene technologies based on the proprietary STREAM™ production platform, exclusively licensed from Grapherry with a pathway to full ownership. Led by CEO Dr. Vikas Berry, Argo is developing a vertically integrated graphene refinery platform designed to connect graphene and graphene oxide production with application development, industrial testing and commercialization.

The Company is evaluating STREAM™ materials across multiple industrial markets, including energy storage, AI infrastructure, construction, composites, semiconductors and advanced electronics, agriculture, coatings and other emerging applications. Argo’s strategy combines advanced-material production, application development, testing, industry collaboration and commercialization.

Complete Financial Solutions' mission is to acquire companies focused on national and economic security priorities. Our team builds the strategies and partnerships with government, military, and law enforcement agencies that accelerate the initiatives needed to assure the security and safety of our nation.

Through five wholly owned subsidiaries spanning defense, aerospace, munitions, real estate, and the outdoor economy, CFS consolidates operations, shares resources, and leverages public markets to fuel growth across the sectors that matter most.

Pioneering the Convergence of AI, Tokenization, and Energy. Empowering the next generation of digital transformation through strategic asset accumulation, technology incubation, and AI infrastructure development to support the Defense and Security of the United States.

Defence Therapeutics is a publicly traded biotechnology company committed to making cancer treatment more effective and safer. Using its Accum® precision drug delivery platform, Defence is working to enhance the potency of ADCs and other complex biologics at lower doses, with the goal of reducing side effects and improving access to advanced therapies. By pursing cutting edge science, and collaborating with pharma and biotech partners, Defence strives to bring transformative therapies to patients who need them most. To learn more about Defence Therapeutics and explore partnering opportunities, please visit www.defencetherapeutics.com or contact info@defencetherapeutics.com.

Eco Wave Power Global (NASDAQ: WAVE) is a renewable energy technology company developing patented onshore and nearshore systems that convert ocean and sea waves into clean electricity. The company’s technology is designed to integrate with existing coastal infrastructure such as breakwaters, piers and jetties, providing a potentially scalable and cost-efficient approach to wave energy generation. Eco Wave Power operates Israel’s first grid-connected wave energy power station and has launched the first onshore wave energy pilot project at the Port of Los Angeles in collaboration with Shell Marine Renewable Energy. The company is advancing additional projects internationally, including in Portugal, Taiwan and India, with a global project pipeline of approximately 404.7 MW.

Investor Highlights

• First-mover position in wave energy, with patented technology that converts ocean and sea waves into clean electricity from existing coastal infrastructure

• Commercial validation underway, including Israel’s first grid-connected wave energy power station and a U.S. pilot project at the Port of Los Angeles

• Global project pipeline of approximately 404.7 MW, with projects and development activity spanning multiple international markets

• Capital-light technology approach, designed for installation on existing breakwaters, piers and other coastal structures rather than offshore deployment

Jaca is a rare sugar that tastes, bakes and cooks like traditional sugar without the consequences. 100% allulose, a rare sugar found in fruit with 90% fewer calories, FDA GRAS status, zero glycemic impact so it's diabetic & keto friendly and it naturally activates GLP-1. The market overall for sugar is $22B in the U.S. and the CAGR for allulose is 32.3%. Jaca’s Amazon revenue grew 470% year over year in June 2026 at 7.8:1 lifetime value to acquisition cost; the company holds a national partnership with Howie Mandel, has filed two U.S. provisional patents for its manufacturing process with Saudi filings underway, completed independent 3rd party Due Diligence, and closed a $1M institutional investment in September 2026. Global Foods Group, LLC (Healthy For Life Foods), Delray Beach, Florida, is a Pending B Corp led by Founder and President Pete Ferrari, 40 years building companies. jacasugar.com

GPOX is an AI-powered distributor modernizing the future of distribution to gas stations and convenience stores with its innovative AI-driven Direct Store Delivery (DSD) model. The Company’s ambitious long-term objective is: “to build the largest nationwide DSD distribution company servicing gas stations, convenience stores, and beyond.” Our technology-driven AI network, featuring strategically placed Regional Hubs and Mini Hubs, is designed to optimize efficiency and maximize reach. Central to our operations is our in-house AI technology platform, PRISM+. Designed to streamline the distribution process, PRISM+ supports efficient delivery, inventory management, data analytics, and overall operational excellence, enabling us to reliably and effectively meet the dynamic needs of our partners. Our mission is to consolidate the fragmented market segment managed by numerous regional vendors. Our dedication to excellence is evident in our product selection process, where we align offerings with consumer demand and partner with top-tier vendors and brands, ensuring our portfolio remains diverse and highly profitable.

For more information, please visit www.GPOPlus.com.

Most doctors sell to a DSO not because they’re ready to retire — but because they’re exhausted from running the business alone.

At HPA, we team with you financially — buying a minority portion of your practice so you capture a financial win now, keep full control, and exit at the highest valuation on your own timeline.

A